Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 1/20 | 0.61 |
| ▸ | CES1 | P23141 | 1/20 | 0.61 |
| ▸ | SRD5A2 | P31213 | 9/20 | 0.48 |
| ▸ | LMNA | P02545 | 3/20 | 0.48 |
| ▸ | MAPT | P10636 | 3/20 | 0.48 |
| ▸ | HTT | P42858 | 2/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.48 |
| ▸ | ESR1 | P03372 | 1/20 | 0.48 |
| ▸ | ESR2 | Q92731 | 1/20 | 0.48 |
| ▸ | PKM | P14618 | 1/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.43 |
| ▸ | TSHR | P16473 | 1/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.41 |
| ▸ | BDKRB2 | P30411 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9541276 | 1.00 | CES2 (0.61) | CES2CES1SRD5A2LMNAMAPT | |
| SCHEMBL118227 | 0.91 | CES2 (0.77) | CES2CES1SRD5A2LMNAMAPT | |
| SCHEMBL7995493 | 0.91 | LMNA (0.55) | CES2CES1SRD5A2LMNAMAPT | |
| SCHEMBL10654851 | 0.91 | SRD5A2 (0.65) | CES2CES1SRD5A2ALDH1A1TSHR | |
| SCHEMBL2976204 | 0.89 | PTPN1 (0.55) | CES2CES1LMNAMAPTHPGD | |
| SCHEMBL1744667 | 0.89 | SRD5A2 (0.57) | CES2CES1SRD5A2LMNAMAPT | |
| SCHEMBL7013140 | 0.89 | ALDH1A1 (0.67) | CES2CES1SRD5A2LMNAHTT | |
| SCHEMBL8546874 | 0.87 | CES2 (0.60) | CES2CES1SRD5A2ALDH1A1KMT2A | |
| SCHEMBL9151945 | 0.85 | CES2 (0.69) | CES2CES1SRD5A2LMNAMAPT | |
| SCHEMBL9541280 | 0.84 | CES2 (0.62) | CES2CES1LMNAMAPTALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4714992-A1 | POLYTETRAMETHYLENE GLYCOL-BASED (METH)ACRYLATE COMPOUND | Cemedine Co., Ltd. (JP) | 2026-03-25 | — | — | EP | disclosed |
| WO-2024242005-A1 | POLYTETRAMETHYLENE GLYCOL-BASED (METH)ACRYLATE COMPOUND | セメダイン株式会社 | 2024-11-28 | — | — | WO | disclosed |
| US-20240207363-A1 | MODIFIED THERAPEUTIC AGENTS, STAPLED PEPTIDE LIPID CONJUGATES, AND COMPOSITIONS THEREOF | THE SCRIPPS RESEARCH INSTITUTE | 2024-06-27 | — | — | US | disclosed |
| US-20240207363-A1 | MODIFIED THERAPEUTIC AGENTS, STAPLED PEPTIDE LIPID CONJUGATES, AND COMPOSITIONS THEREOF | THE SCRIPPS RESEARCH INSTITUTE | 2024-06-27 | — | — | US | disclosed |
| US-20240191003-A1 | COMPOSITION AND PHOTOSENSITIVE COMPOSITION | TOKYO OHKA KOGYO CO., LTD. (JP) | 2024-06-13 | — | — | US | disclosed |
| CN-117908327-A | Composition and photosensitive composition | 东京应化工业株式会社 | 2024-04-19 | — | — | CN | disclosed |
| EP-4212180-A1 | MODIFIED THERAPEUTIC AGENTS, STAPLED PEPTIDE LIPID CONJUGATES, AND COMPOSITIONS THEREOF | The Scripps Research Institute (US) | 2023-07-19 | — | — | EP | disclosed |
| US-11701345-B2 | Car activator agents for cyclophosphamide-based treatments of cancer | UNIVERSITY OF MARYLAND, BALTIMORE (US) | 2023-07-18 | — | — | US | disclosed |
| US-20230210800-A1 | HYDROXYL COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES | ESPERION THERAPEUTICS INC (US) | 2023-07-06 | — | — | US | disclosed |
| US-20230119640-A1 | ANTIBACTERIAL HYDROPHILIC COMPOUND | SHENZHEN UNIVERSITY (CN) | 2023-04-20 | — | — | US | disclosed |
| EP-0435687-A2 | Process for isomerization of oxime ethers | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1991-07-03 | — | — | EP | disclosed |
| EP-0119219-B1 | COATING COMPOSITIONS AND THEIR USE IN THE RESTORATIVE AND/OR PROTECTIVE TREATMENT OF PHOTOGRAPHIC ELEMENTS | EASTMAN KODAK COMPANY (a New Jersey corporation) (US) | 1986-07-23 | — | — | EP | disclosed |
| US-4552830-A | UNSATURATED COMPOUND, FREE RADICAL-PRODUCING PHOTOINITIATOR FLUORA COLOR FORMER, PROTON DONOR | DYNACHEM CORPORATION (US) | 1985-11-12 | — | — | US | disclosed |
| US-4343885-A | PHOTORESISTS | DYNACHEM CORPORATION (US) | 1982-08-10 | — | — | US | disclosed |
| EP-0002805-B1 | PHOTOPOLYMERIZABLE COATING AND REGISTRATION MATERIALS,SUCH AS TRANSFER FOILS WITH A PHOTOSENSIBLE COATING AND PHOTORESIST MATERIALS, CONTAINING A PHOTOINITIATOR AND AN ORGANIC HALOGEN COMPOUND | BASF Aktiengesellschaft (DE) | 1981-01-07 | — | — | EP | disclosed |
| US-4239609-A | PHOTORESISTS, RELIEF IMAGES | BASF AKTIENGESELLSCHAFT (DE) | 1980-12-16 | — | — | US | disclosed |
| EP-0002805-A1 | Photopolymerizable coating and registration materials,such as transfer foils with a photosensible coating and photoresist materials, containing a photoinitiator and an organic halogen compound | BASF Aktiengesellschaft (DE) | 1979-07-11 | — | — | EP | disclosed |
| US-4107012-A | COATINGS, PRINTING INKS | BAYER AKTIENGESELLSCHAFT (DE) | 1978-08-15 | — | — | US | disclosed |
| US-4080382-A | Haloalkyl benzophenone compounds suitable for use as initiators for photopolymerization | EASTMAN KODAK COMPANY (US) | 1978-03-21 | — | — | US | disclosed |
| US-4043887-A | Benzophenone initiators for the photopolymerization of unsaturated compounds | EASTMAN KODAK COMPANY (US) | 1977-08-23 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11701345-B2 | Car activator agents for cyclophosphamide-based treatments of cancer | CYP2A6, CYP2B6, CYP4A11 | CES2 95/4885CES1 94/4885SRD5A2 388/4885 |
| US-20240207363-A1 | MODIFIED THERAPEUTIC AGENTS, STAPLED PEPTIDE LIPID CONJUGATES, AND COMPOSITIONS THEREOF | SGMS1, SGMS2, PHOSPHO1 | CES2 4147/4885CES1 2096/4885SRD5A2 4775/4885 |
| US-20230210800-A1 | HYDROXYL COMPOUNDS AND COMPOSITIONS FOR CHOLESTEROL MANAGEMENT AND RELATED USES | CYP27A1, NR1H3, PNLIP | CES2 2238/4885CES1 250/4885SRD5A2 130/4885 |
| US-20230119640-A1 | ANTIBACTERIAL HYDROPHILIC COMPOUND | HIRA, NOD2, CHLSN | CES2 887/4885CES1 3525/4885SRD5A2 4464/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.